Epoetin alfa for protection of metabolic and exercise capacity in cancer patients

被引:19
作者
Daneryd, P [1 ]
机构
[1] Univ Gothenburg, Gothenburg, Sweden
关键词
D O I
10.1053/sonc.2002.33537
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:69 / 74
页数:6
相关论文
共 9 条
[1]  
Bertero MT, 1997, HAEMATOLOGICA, V82, P375
[2]  
Daneryd P, 1998, CANCER RES, V58, P5374
[3]   Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: Results from a prospective community oncology study [J].
Demetri, GD ;
Kris, M ;
Wade, J ;
Degos, L ;
Cella, D .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (10) :3412-3425
[4]   Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: Improvements in hemoglobin and quality of life are similar to three-times-weekly dosing [J].
Gabrilove, JL ;
Cleeland, CS ;
Livingston, RB ;
Sarokhan, B ;
Winer, E ;
Einhorn, LH .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (11) :2875-2882
[5]   Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice [J].
Glaspy, J ;
Bukowski, R ;
Steinberg, D ;
Taylor, C ;
Tchekmedyian, S ;
VadhanRaj, S .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) :1218-1234
[6]   ELEVATED ENERGY-EXPENDITURE IN CANCER-PATIENTS WITH SOLID TUMORS [J].
HYLTANDER, A ;
DROTT, C ;
KORNER, U ;
SANDSTROM, R ;
LUNDHOLM, K .
EUROPEAN JOURNAL OF CANCER, 1991, 27 (01) :9-15
[7]   Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: Results of a randomized, double-blind, placebo-controlled trial [J].
Littlewood, TJ ;
Bajetta, E ;
Nortier, JWR ;
Vercammen, E ;
Rapoport, B .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (11) :2865-2874
[8]  
LUNDHOLM K, 1994, CANCER RES, V54, P5602
[9]   Anemia of cancer [J].
Moliterno, AR ;
Spivak, JL .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1996, 10 (02) :345-+